The Discounted Cash Flow (DCF) valuation of Lumos Pharma Inc (LUMO) is (114.94) USD. With the latest stock price at 4.34 USD, the upside of Lumos Pharma Inc based on DCF is -2748.5%.
Based on the latest price of 4.34 USD and our DCF valuation, Lumos Pharma Inc (LUMO) is a sell. selling LUMO stocks now will result in a potential gain of 2748.5%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.3% - 8.0% | 7.2% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (262.23) - (75.05) | (114.94) |
| Upside | -6142.2% - -1829.2% | -2748.5% |